Selective targeting of cancer cells by copper ionophores: an overview
V Oliveri - Frontiers in molecular biosciences, 2022 - frontiersin.org
Conventional cancer therapies suffer from severe off-target effects because most of them
target critical facets of cells that are generally shared by all rapidly proliferating cells. The …
target critical facets of cells that are generally shared by all rapidly proliferating cells. The …
Toward multi-targeted platinum and ruthenium drugs—a new paradigm in cancer drug treatment regimens?
RG Kenny, CJ Marmion - Chemical reviews, 2019 - ACS Publications
While medicinal inorganic chemistry has been practised for over 5000 years, it was not until
the late 1800s when Alfred Werner published his ground-breaking research on coordination …
the late 1800s when Alfred Werner published his ground-breaking research on coordination …
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Tumor cells metabolize in distinct pathways compared with most normal tissue cells. The
resulting tumor microenvironment would provide characteristic physiochemical conditions …
resulting tumor microenvironment would provide characteristic physiochemical conditions …
Stimuli-responsive therapeutic metallodrugs
The success of platinum-based anticancer agents has motivated the exploration of novel
metal-based drugs for several decades, whereas problems such as drug-resistance and …
metal-based drugs for several decades, whereas problems such as drug-resistance and …
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
Glycosylation is a well-regulated cell and microenvironment specific post-translational
modification. Several glycosyltransferases and glycosidases orchestrate the addition of …
modification. Several glycosyltransferases and glycosidases orchestrate the addition of …
Specific “unlocking” of a nanozyme‐based butterfly effect to break the evolutionary fitness of chaotic tumors
W Zhen, Y Liu, W Wang, M Zhang, W Hu… - Angewandte …, 2020 - Wiley Online Library
Chaos and the natural evolution of tumor systems can lead to the failure of tumor therapies.
Herein, we demonstrate that iridium oxide nanoparticles (IrOx) possess acid‐activated …
Herein, we demonstrate that iridium oxide nanoparticles (IrOx) possess acid‐activated …
Chitosan–Biotin-Conjugated PH-Responsive Ru (II) Glucose Nanogel: A Dual Pathway of Targeting Cancer Cells and Self-Drug Delivery
The current study paves the way for improved chemotherapy by creating pH-responsive
nanogels (NGs)(GC1 and GC2) loaded with synthetic ruthenium (II) arene complexes to …
nanogels (NGs)(GC1 and GC2) loaded with synthetic ruthenium (II) arene complexes to …
[HTML][HTML] Single-chain polymer nanoparticles in biomedical applications
Single-chain polymer nanoparticles (SCNPs) are a well-defined and uniquely sized class of
polymer nanoparticles. The advances in polymer science over the past decades have …
polymer nanoparticles. The advances in polymer science over the past decades have …
Developments in carbohydrate-based cancer therapeutics
Cancer cells of diverse origins express extracellular tumor-specific carbohydrate antigens
(TACAs) because of aberrant glycosylation. Overexpressed TACAs on the surface of tumor …
(TACAs) because of aberrant glycosylation. Overexpressed TACAs on the surface of tumor …